Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$238.3m

Shenzhen Neptunus Interlong Bio-technique Balance Sheet Health

Financial Health criteria checks 5/6

Shenzhen Neptunus Interlong Bio-technique has a total shareholder equity of CN¥1.0B and total debt of CN¥89.7M, which brings its debt-to-equity ratio to 8.8%. Its total assets and total liabilities are CN¥1.4B and CN¥399.5M respectively. Shenzhen Neptunus Interlong Bio-technique's EBIT is CN¥50.2M making its interest coverage ratio -41.2. It has cash and short-term investments of CN¥382.2M.

Key information

8.8%

Debt to equity ratio

CN¥89.69m

Debt

Interest coverage ratio-41.2x
CashCN¥382.21m
EquityCN¥1.02b
Total liabilitiesCN¥399.46m
Total assetsCN¥1.42b

Recent financial health updates

Recent updates

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Apr 19
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Financial Position Analysis

Short Term Liabilities: 8329's short term assets (CN¥920.6M) exceed its short term liabilities (CN¥366.2M).

Long Term Liabilities: 8329's short term assets (CN¥920.6M) exceed its long term liabilities (CN¥33.3M).


Debt to Equity History and Analysis

Debt Level: 8329 has more cash than its total debt.

Reducing Debt: 8329's debt to equity ratio has increased from 1.1% to 8.8% over the past 5 years.

Debt Coverage: 8329's debt is well covered by operating cash flow (59.9%).

Interest Coverage: 8329 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.